- Home
- AARD vs SJT Comparison
AARD vs SJT Comparison
Compare AARD & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- SJT
- Stock Information
- Founded
- AARD 2017
- SJT 1980
- Country
- AARD United States
- SJT United States
- Employees
- AARD N/A
- SJT N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- SJT Oil & Gas Production
- Sector
- AARD Health Care
- SJT Energy
- Exchange
- AARD Nasdaq
- SJT Nasdaq
- Market Cap
- AARD 271.1M
- SJT 280.6M
- IPO Year
- AARD 2025
- SJT N/A
- Fundamental
- Price
- AARD $11.50
- SJT $5.85
- Analyst Decision
- AARD Strong Buy
- SJT
- Analyst Count
- AARD 5
- SJT 0
- Target Price
- AARD $33.00
- SJT N/A
- AVG Volume (30 Days)
- AARD 37.2K
- SJT 181.5K
- Earning Date
- AARD 08-18-2025
- SJT 08-18-2025
- Dividend Yield
- AARD N/A
- SJT N/A
- EPS Growth
- AARD N/A
- SJT N/A
- EPS
- AARD N/A
- SJT 0.02
- Revenue
- AARD N/A
- SJT $1,931,777.00
- Revenue This Year
- AARD N/A
- SJT N/A
- Revenue Next Year
- AARD N/A
- SJT N/A
- P/E Ratio
- AARD N/A
- SJT $254.99
- Revenue Growth
- AARD N/A
- SJT N/A
- 52 Week Low
- AARD $4.88
- SJT $3.21
- 52 Week High
- AARD $19.58
- SJT $7.22
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- SJT 44.04
- Support Level
- AARD N/A
- SJT $5.77
- Resistance Level
- AARD N/A
- SJT $6.42
- Average True Range (ATR)
- AARD 0.00
- SJT 0.17
- MACD
- AARD 0.00
- SJT 0.00
- Stochastic Oscillator
- AARD 0.00
- SJT 37.21
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.